HLB PHARMACEUTICAL CO., LTD.

Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.

047920 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 남양주시 경강로 27, 남양주시
Website:: https://www.hlbpharma.co.kr/eng/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pharmaceutical Co., Ltd. is a research-driven pharmaceutical company specializing in the development and manufacturing of innovative treatments. The company's core activities center on researching and developing new drugs, including peptide-based therapies and a pipeline of anti-cancer treatments, as part of its vision to become a global oncology firm. In addition to its R&D, HLB Pharmaceutical provides Contract Manufacturing Organization (CMO) services, utilizing its advanced facilities and rigorous quality management systems to produce high-quality medicines. The company also manufactures quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices, and its portfolio includes products like skeletal muscle relaxants.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB PHARMACEUTICAL CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HLB PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HLB PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ChoA Pharmaceutical Co., LTD. Global manufacturer of OTC medicines and health supplements distributed through pharmacies.	South Korea	034940
CHUGAI PHARMACEUTICAL CO., LTD. An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.	Japan	4519
Cinclus Pharma Holding AB Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.	Sweden	CINPHA
Circio Holding ASA Developing circular RNA vector tech and immunotherapies for gene and cell therapies.	Norway	CRNA
CJ Bioscience Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.	South Korea	311690
CKD Bio Corp. Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.	South Korea	063160
CMG Pharmaceutical Co., Ltd. Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.	South Korea	058820
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Compugen Ltd. Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.	Israel	CGEN
CORESTEMCHEMON Inc. Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.	South Korea	166480